Enhancing viscosity control in antibody formulations: A framework for the biophysical screening of mutations targeting solvent-accessible hydrophobic and electrostatic patches
Armstrong, G. B.; Shah, V.; Sanches, P.; Patel, M.; Casey, R.; Jamieson, C. J.; Burley, G. A.; Lewis, W. J.; Rattray, Z.
Show abstract
The formulation of high-concentration monoclonal antibody (mAb) solutions in low dose volumes for autoinjector devices poses challenges in manufacturability and patient administration due to elevated solution viscosity. In the current study, we present a systematic experimental framework for the computational screening of molecular descriptors to guide the design of mutants with modified viscosity profiles accompanied by experimental evaluation. Our observations using a model anti-IL8 antibody reveal that the reduction in viscosity is influenced by the location of hydrophobic interactions, while targeting positively charged patches in mAb1 leads to the most significant viscosity increase compared to the wild-type mAb. We conclude that existing in silico predictions of physicochemical properties exhibit poor correlation with experimental parameters for antibodies with suboptimal developability characteristics, emphasizing the necessity for comprehensive case-by-case evaluations of mAbs. This approach aids in the rational design of mAbs with tailored solution viscosities, ensuring improved manufacturability and patient convenience in self-administration scenarios.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Temperature and Excipient Mediated Modulation of Monoclonal Antibody Interactions Revealed by kD, Rheology, and Raman Spectroscopy 94%
- Enhancement of antibody thermostability and affinity by computational design in the absence of antigen 94%
- Predicting purification process fit of monoclonal antibodies using machine learning 94%
Similar papers in this journal
- Machine learning driven acceleration of biopharmaceutical formulation development using Excipient Prediction Software (ExPreSo) 94%
- DeepSCM: an efficient convolutional neural network surrogate model for the screening of therapeutic antibody viscosity 94%
- DeepSP: Deep Learning-Based Spatial Properties to Predict Monoclonal Antibody Stability 94%
Similar papers in this journal
- Exploring the Extreme Acid Tolerance of a Dynamic Protein Nanocage 93%
- Applying computational protein design to engineer affibodies for affinity-controlled delivery of vascular endothelial growth factor and platelet-derived growth factor 93%
- Engineering a virus-like particle to display peptide insertions using an apparent fitness landscape 92%
Similar papers in this journal
- Mechanistic insights into the activation of lecithin-cholesterol acyltransferase in therapeutic nanodiscs composed of apolipoprotein A-I mimetic peptides and phospholipids 92%
- Dynamics of Human Serum Transferrin in Varying Physicochemical Conditions Explored by Using Molecular Dynamics Simulations 90%
- A silk-based platform to stabilize phenylalanine ammonia-lyase (PAL) for orally administered enzyme replacement therapy 90%
Similar papers in this journal
- Unveiling the three-step model for the interaction of imidazolium-based ionic liquids on albumin 92%
- Intracellular biomacromolecule delivery by stimuli responsive protein vesicles loaded by hydrophobic ion pairing 92%
- Signal Peptide of Human Serum Albumin (residues 1-18) Forms Amyloid-like Aggregates 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.